Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
40,53 € ↓ -2,45 (-5,70%)
2026-06-05
DEL PRIS
SecurityDE:12V / Veracyte, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership496,219 shares
Latest Disclosed Value $ 15,104,907
Jpmorgan Chase & Co ownership in 12V / Veracyte, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 496,219 shares of Veracyte, Inc. (DE:12V) valued at $13,199,425 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 520,129 shares of Veracyte, Inc.. This represents a change in shares of -4.60% during the quarter. The current value of the position is $20,111,756 USD.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (12V) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:12V / Veracyte, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 VERACYTE COMMON 92337F107 496,219 -23,910 -4.60 15,105 -31.02 0.0001
2026-05-13 2026-03-31 13F VERACYTE COMMON 92337F107 0 -100.00 0
2026-02-11 2025-12-31 13F VERACYTE COMMON 92337F107 520,129 1,279 0.25 21,897 22.93 0.0014
2025-11-26 2025-09-30 13F/A-1 VERACYTE COMMON 92337F107 518,850 181,872 53.97 17,812 95.56 0.0011
2025-11-07 2025-09-30 13F VERACYTE COMMON 92337F107 518,850 181,872 17,812 0.0011
2025-08-12 2025-06-30 13F VERACYTE COMMON 92337F107 336,978 243,111 259.00 9,109 227.27 0.0006
2025-05-12 2025-03-31 13F VERACYTE COMMON 92337F107 93,867 -341,104 -78.42 2,783 -83.84 0.0002
2025-02-12 2024-12-31 13F VERACYTE COMMON 92337F107 434,971 88,384 25.50 17,225 46.00 0.0013
2024-12-26 2024-09-30 13F/A-1 VERACYTE COMMON 92337F107 346,587 -2,543 -0.73 11,798 55.94 0.0009
2024-11-08 2024-09-30 13F VERACYTE COMMON 92337F107 346,587 -2,543 11,798 0.0009
2024-12-26 2024-06-30 13F/A-1 VERACYTE COMMON 92337F107 349,130 268,466 332.82 7,566 323.34 0.0006
2024-08-12 2024-06-30 13F VERACYTE COMMON 92337F107 349,130 268,466 7,566 0.0006
2024-12-26 2024-03-31 13F/A-1 VERACYTE COMMON 92337F107 80,664 -36,579 -31.20 1,788 -44.59 0.0002
2024-05-10 2024-03-31 13F VERACYTE COMMON 92337F107 80,664 -36,579 1,788 0.0002
2024-12-26 2023-12-31 13F/A-1 VERACYTE COMMON 92337F107 117,243 -143,623 -55.06 3,225 -44.64 0.0003
2024-02-12 2023-12-31 13F VERACYTE COMMON 92337F107 117,243 -143,623 3,225 0.0003
2023-11-14 2023-09-30 13F VERACYTE COMMON 92337F107 260,866 -8,063 -3.00 5,825 -14.95 0.0006
2023-08-11 2023-06-30 13F VERACYTE COMMON 92337F107 268,929 176,275 190.25 6,850 231.51 0.0007
2023-05-18 2023-03-31 13F/A-1 VERACYTE COMMON 92337F107 92,654 -292,795 -75.96 2,066 22,855.56 0.0003
2023-05-11 2023-03-31 13F VERACYTE COMMON 92337F107 2,620 -382,829 842 0.0000
2023-02-13 2022-12-31 13F VERACYTE COMMON 92337F107 385,449 61,210 18.88 9 -99.83 0.0012
2022-11-14 2022-09-30 13F VERACYTE COMMON 92337F107 324,239 256,867 381.27 5,383 301.72 0.0008
2022-08-11 2022-06-30 13F VERACYTE COMMON 92337F107 67,372 12,052 21.79 1,340 -12.13 0.0002
2022-05-11 2022-03-31 13F VERACYTE COMMON 92337F107 55,320 9,589 20.97 1,525 -19.06 0.0002
2022-02-11 2021-12-31 13F/A-1 VERACYTE COMMON 92337F107 45,731 2,094 4.80 1,884 -7.10 0.0002
2022-02-10 2021-12-31 13F VERACYTE COMMON 92337F107 45,731 2,094 1,884 0.0000
2021-11-12 2021-09-30 13F VERACYTE COMMON 92337F107 43,637 -15,359 -26.03 2,028 -14.03 0.0003
2021-08-12 2021-06-30 13F VERACYTE COMMON 92337F107 58,996 7,601 14.79 2,359 -14.62 0.0003
2021-05-12 2021-03-31 13F VERACYTE COMMON 92337F107 51,395 24,133 88.52 2,763 107.12 0.0004
2021-02-19 2020-12-31 13F/A-1 VERACYTE COMMON 92337F107 27,262 -9,672 -26.19 1,334 10.16 0.0002
2021-02-11 2020-12-31 13F VERACYTE COMMON 92337F107 27,262 -9,672 1,334 32.9908
2020-11-12 2020-09-30 13F/A-1 VERACYTE COMMON 92337F107 36,934 18,889 104.68 1,211 159.31 0.0002
2020-11-12 2020-09-30 13F VERACYTE COMMON 92337F107 36,934 1,211
2020-08-11 2020-06-30 13F VERACYTE COMMON 92337F107 18,045 2,487 15.99 467 23.54 0.0001
2020-05-12 2020-03-31 13F VERACYTE COMMON 92337F107 15,558 -68,026 -81.39 378 -83.80 0.0001
2020-02-11 2019-12-31 13F VERACYTE COMMON 92337F107 83,584 2,725 3.37 2,334 20.31 0.0004
2019-11-12 2019-09-30 13F VERACYTE COMMON 92337F107 80,859 68,063 531.91 1,940 472.27 0.0004
2019-08-07 2019-06-30 13F VERACYTE COMMON 92337F107 12,796 5,893 85.37 339 95.95 0.0001
2019-05-07 2019-03-31 13F VERACYTE COMMON 92337F107 6,903 -69,749 -90.99 173 -82.05 0.0000
2019-02-11 2018-12-31 13F VERACYTE COMMON 92337F107 76,652 -246,736 -76.30 964 -68.79 0.0002
2018-11-13 2018-09-30 13F/A-1 VERACYTE COMMON 92337F107 323,388 133,469 70.28 3,089 74.13 0.0006
2018-11-07 2018-09-30 13F VERACYTE COMMON 92337F107 323,388 133,469 3,089
2018-08-14 2018-06-30 13F VERACYTE COMMON 92337F107 189,919 60,653 46.92 1,774 146.73 0.0004
2018-05-10 2018-03-31 13F VERACYTE COMMON 92337F107 129,266 124,156 2,429.67 719 2,078.79 0.0002
2018-02-13 2017-12-31 13F VERACYTE COMMON 92337F107 5,110 -13,795 -72.97 33 -79.37 0.0000
2017-11-09 2017-09-30 13F VERACYTE COMMON 92337F107 18,905 18,905 160 0.0000
2017-08-09 2017-06-30 13F VERACYTE COMMON 92337F107 0 -49,765 -100.00 0 -100.00
2017-05-10 2017-03-31 13F VERACYTE COMMON 92337F107 49,765 26,186 111.06 456 149.18 0.0001
2017-02-06 2016-12-31 13F VERACYTE COMMON 92337F107 23,579 16,941 255.21 183 258.82 0.0000
2016-11-04 2016-09-30 13F VERACYTE COMMON 92337F107 6,638 6,638 51 0.0000
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-08-08 2016-06-30 13F VERACYTE OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-10 2016-03-31 13F VERACYTE OPTION Put 25,000 135 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.